P J Miller|M Constantinides|S K Galli - JoVE Visualize

Showing results (81-90 of 130) with videos related to

Pageof 13

Sort By:

Head & Neck|September 1, 1996

Intracranial inverting papillomaP J Miller, J Jacobs, J T Roland, et al.

The Journal of Experimental Medicine|March 1, 1985

Analysis of human blood monocyte activation at the level of gene expression. Expression of alpha interferon genes during activation of human monocytes by poly IC/LC and muramyl dipeptideH C Stevenson, G A Dekaban, P J Miller, et al.

Regulatory Peptides|December 14, 1995

A functional comparison of the rat type-1 angiotensin II receptors (AT1AR and AT1BR)M M Martin, C R White, H Li, et al.

Biochemical and Biophysical Research Communications|November 15, 1994

The genomic organization and functional analysis of the promoter for the human angiotensin II type 1 receptorB Su, M M Martin, K B Beason, et al.

Journal of Leukocyte Biology|May 1, 1985

Differential ability of human blood monocyte subsets to release various cytokinesY Akiyama, G W Stevenson, E Schlick, et al.

Experimental Neurology|May 1, 1997

Intracerebroventricular glial cell line-derived neurotrophic factor improves motor function and supports nigrostriatal dopamine neurons in bilaterally 6-hydroxydopamine lesioned ratsK E Bowenkamp, P A Lapchak, B J Hoffer, et al.

ASAIO Journal (American Society for Artificial Internal Organs : 1992)|May 26, 2001

Pressure-volume relationship of a pulsatile blood pump for ventricular assist device developmentY C Yu, J R Boston, M A Simaan, et al.

Journal of Immunological Methods|December 16, 1983

Utilization of purified human monocytes in the agarose droplet assay for measuring migration inhibitory factorsG B Thurman, H B Stull, P J Miller, et al.

Tropical Animal Health and Production|March 17, 2019

Epidemiology, control, and prevention of Newcastle disease in endemic regions: Latin AmericaA E Absalón, Diana V Cortés-Espinosa, E Lucio, et al.

Oncogenesis|March 31, 2015

Inhibiting phosphorylation of the oncogenic PAX3-FOXO1 reduces alveolar rhabdomyosarcoma phenotypes identifying novel therapy optionsJ M Loupe, P J Miller, D R Ruffin, et al.

Pageof 13

Showing results (81-90 of 130) with videos related to

Sort By:

Pageof 13

Head & Neck|September 1, 1996

Intracranial inverting papillomaP J Miller, J Jacobs, J T Roland, et al.

The Journal of Experimental Medicine|March 1, 1985

Analysis of human blood monocyte activation at the level of gene expression. Expression of alpha interferon genes during activation of human monocytes by poly IC/LC and muramyl dipeptideH C Stevenson, G A Dekaban, P J Miller, et al.

Regulatory Peptides|December 14, 1995

A functional comparison of the rat type-1 angiotensin II receptors (AT1AR and AT1BR)M M Martin, C R White, H Li, et al.

Biochemical and Biophysical Research Communications|November 15, 1994

The genomic organization and functional analysis of the promoter for the human angiotensin II type 1 receptorB Su, M M Martin, K B Beason, et al.

Journal of Leukocyte Biology|May 1, 1985

Differential ability of human blood monocyte subsets to release various cytokinesY Akiyama, G W Stevenson, E Schlick, et al.

Experimental Neurology|May 1, 1997

Intracerebroventricular glial cell line-derived neurotrophic factor improves motor function and supports nigrostriatal dopamine neurons in bilaterally 6-hydroxydopamine lesioned ratsK E Bowenkamp, P A Lapchak, B J Hoffer, et al.

ASAIO Journal (American Society for Artificial Internal Organs : 1992)|May 26, 2001

Pressure-volume relationship of a pulsatile blood pump for ventricular assist device developmentY C Yu, J R Boston, M A Simaan, et al.

Journal of Immunological Methods|December 16, 1983

Utilization of purified human monocytes in the agarose droplet assay for measuring migration inhibitory factorsG B Thurman, H B Stull, P J Miller, et al.

Tropical Animal Health and Production|March 17, 2019

Epidemiology, control, and prevention of Newcastle disease in endemic regions: Latin AmericaA E Absalón, Diana V Cortés-Espinosa, E Lucio, et al.

Oncogenesis|March 31, 2015

Inhibiting phosphorylation of the oncogenic PAX3-FOXO1 reduces alveolar rhabdomyosarcoma phenotypes identifying novel therapy optionsJ M Loupe, P J Miller, D R Ruffin, et al.

Pageof 13